Lasofoxifene Tartrate CAS 190791-29-8 Mimọ Chiral ≥99.0% Mimọ

Apejuwe kukuru:

Orukọ Kemikali: Lasofoxifene Tartrate

CAS: 190791-29-8

Irisi: Funfun si Paa-White Powder

Mimọ Chiral: ≥99.0%Mimọ: ≥98.0% (HPLC)

Ni itọju Postmenopausal Osteoporosis

API Didara Giga, Iṣelọpọ Iṣowo

Inquiry: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Olupese pẹlu Iwa-mimọ giga ati Didara Idurosinsin
Orukọ Kemikali: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) ni itọju Postmenopausal Osteoporosis

Kemikali Properties:

Orukọ Kemikali	Lasofoxifene Tartrate
Awọn itumọ ọrọ sisọ	(5R,6S) -5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2- (1-pyrrolidinyl) ethoxy] phenyl] -2-naphthalenol Tartrate Oporia
Nọmba CAS	Ọdun 190791-29-8
NỌMBA CAT	RF-API20
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram
Fọọmu Molecular	C28H31NO2.ClH
Òṣuwọn Molikula	450.019
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun to Pa-White Powder
Ọrinrin (KF)	≤0.50%
Awọn irin Heavy	≤20ppm
Chiral Mimọ	≥99.0%
Mimọ / Analysis Ọna	≥98.0% (HPLC)
Pipadanu lori Gbigbe	≤0.50%
Aloku lori Iginisonu	≤0.50%
Igbeyewo Standard	Pharmacopoeia Kannada (CP);Standard Enterprise
Lilo	Ohun elo elegbogi ti nṣiṣe lọwọ (API);Osteoporosis postmenopausal

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

FAQ:

Ohun elo:

Shanghai Ruifu Kemikali Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti Lasofoxifene Tartrate (CAS: 190791-29-8) pẹlu didara to gaju.
Lasofoxifene Tartrate jẹ iran-kẹta kan, ti kii-sitẹriọdu yiyan estrogen receptor modulator (SERM).O ni yiyan sopọ mọ ERalpha eniyan pẹlu iye IC50 ti 1.5 nM ati ṣe idiwọ pipadanu egungun ni awọn eku ovariectomized.Ninu awọn iwadii ile-iwosan ti osteoporosis postmenopausal, 0.5 mg / ọjọ lasofoxifene ni nkan ṣe pẹlu awọn ewu ti o dinku ti awọn eewu ti kii ṣe vertebral ati vertebral, ER-positive akàn igbaya, arun ọkan iṣọn-alọ ọkan, ati ọpọlọ ṣugbọn eewu ti o pọ si ti awọn iṣẹlẹ thromboembolic iṣọn-ẹjẹ.Lasofoxifene tun ti han lati ṣe bi agonist onidakeji ni olugba CB2 cannabinoid, nfihan agbara rẹ lati tun pada bi itọju ailera fun awọn itọkasi nibiti CB2 jẹ ibi-afẹde.